NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017.
Publication
, Journal Article
Benson, AB; D'Angelica, MI; Abbott, DE; Abrams, TA; Alberts, SR; Saenz, DA; Are, C; Brown, DB; Chang, DT; Covey, AM; Hawkins, W; Iyer, R ...
Published in: J Natl Compr Canc Netw
May 2017
The NCCN Guidelines for Hepatobiliary Cancers provide treatment recommendations for cancers of the liver, gallbladder, and bile ducts. The NCCN Hepatobiliary Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding locoregional therapy for treatment of patients with hepatocellular carcinoma.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
May 2017
Volume
15
Issue
5
Start / End Page
563 / 573
Location
United States
Related Subject Headings
- United States
- Oncology & Carcinogenesis
- Liver Neoplasms
- Humans
- Carcinoma, Hepatocellular
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Benson, A. B., D’Angelica, M. I., Abbott, D. E., Abrams, T. A., Alberts, S. R., Saenz, D. A., … Darlow, S. (2017). NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017. J Natl Compr Canc Netw, 15(5), 563–573. https://doi.org/10.6004/jnccn.2017.0059
Benson, Al B., Michael I. D’Angelica, Daniel E. Abbott, Thomas A. Abrams, Steven R. Alberts, Daniel Anaya Saenz, Chandrakanth Are, et al. “NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017.” J Natl Compr Canc Netw 15, no. 5 (May 2017): 563–73. https://doi.org/10.6004/jnccn.2017.0059.
Benson AB, D’Angelica MI, Abbott DE, Abrams TA, Alberts SR, Saenz DA, et al. NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017. J Natl Compr Canc Netw. 2017 May;15(5):563–73.
Benson, Al B., et al. “NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017.” J Natl Compr Canc Netw, vol. 15, no. 5, May 2017, pp. 563–73. Pubmed, doi:10.6004/jnccn.2017.0059.
Benson AB, D’Angelica MI, Abbott DE, Abrams TA, Alberts SR, Saenz DA, Are C, Brown DB, Chang DT, Covey AM, Hawkins W, Iyer R, Jacob R, Karachristos A, Kelley RK, Kim R, Palta M, Park JO, Sahai V, Schefter T, Schmidt C, Sicklick JK, Singh G, Sohal D, Stein S, Tian GG, Vauthey J-N, Venook AP, Zhu AX, Hoffmann KG, Darlow S. NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017. J Natl Compr Canc Netw. 2017 May;15(5):563–573.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
May 2017
Volume
15
Issue
5
Start / End Page
563 / 573
Location
United States
Related Subject Headings
- United States
- Oncology & Carcinogenesis
- Liver Neoplasms
- Humans
- Carcinoma, Hepatocellular
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis